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SI Materials and Methods
Strains, Plasmids, and Culture Conditions. Escherichia coli strains
BL21(DE3), BL21(DE3)pLysS, BL21(DE3)pLysE,
Lemo21(DE3), Lemo41(DE3), Lemo43(DE3), C41(DE3), and
C43(DE3) were used in this study (1, 2). Lemo indicates that cells
harbor a pACYC-derived plasmid with the gene encoding T7
lysozyme under control of an L-rhamnose inducible promoter (Fig.
S5). Proteins [E. coli EnvZ, GltP, PheP, PstA, RarD, UhpT, YfbF,
YiaM, YidC, YijD, YqcE, Shewanella oneidensis transporter A
(SOTA), and the rat neurotensin receptor (NTR) N-terminally
fused to the maltose binding protein, and the human tetraspannins
(Tsp) A and B)] were overexpressed as GFP fusions from a
pET28a derived vector as described (3–5). The gene encoding the
MBP-NTR fusion protein was amplified from vector pMalp-2-
NTR-HMTX (6) by using the primers ‘‘pMBPXhoIf’’ and
‘‘NTRKpnIr’ and was subsequently cloned into pGFPe digested
with XhoI and KpnI. Primer sequences are listed in Table S4.
eGFP-His was expressed from a pET20b vector (7). Cells were
grown aerobically in standard Luria-Bertani broth supplemented
with kanamycin (50g/ml) and if cells harbored pLemo or pLysS/E
also chloramphenicol (30 g/ml). Over night cultures were diluted
1:50. Cultures were grown in shaker flasks at 30°C in an Innova 4330
(New Brunswick Scientific) shaker at 180 rpm. Growth was mon-
itored by measuring the OD600 with a Shimadzu UV-1601 spec-
trophotometer. T7 lysozyme expression was induced by addition of
10–2000 M L-rhamnose to the culture medium. For all experi-
ments, protein expression was induced by the addition of 0.4 mM
isopropyl--D-thiogalactopyranoside (IPTG) (final concentration)
at an OD600 of 0.4–0.5. Cells were harvested at the indicated time
points after induction.
GFP Fluorescence Measurements and Flow Cytometry. Expression of
recombinant protein-GFP fusions and GFP was monitored by
measuring whole cell GFP fluorescence in a spectrofluorometer
and in-gel as described before (3, 7). In-gel f luorescence showed
that in all experiments 95% of the overexpressed material was
full-length fusion. For on-line fluorescence measurements cells
were cultured in a 96-well plate in a spectrofluorometer. Anal-
ysis of cells overexpressing GFP-fusion proteins and control cells
by means of flow cytometry was done as described before by
using a FACSCalibur (BD Biosciences) instrument (8).
Purification of mRNA, Reverse Transcription, and Quantitative PCR.
For the purification of total RNA, 0.5 A600 unit of bacterial
culture was added to two times the volume of RNAprotect Bacteria
Reagent (Qiagen). After mixing and 5-min incubation at room
temperature, bacteria were collected by centrifugation. Cells were
lysed and RNA extracted with the RNeasy kit (Qiagen). After
elution, nucleic acid concentrations were determined by spectro-
photometry (NanoVue, GE Healthcare) and residual DNA was
removed by incubating the samples with 2 U of TURBO DNase
(Ambion). After DNase inactivation, RNA was recovered, quan-
tified, and used for first-strand cDNA synthesis by usingOmniscript
Reverse Transcriptase (Qiagen). For cDNA synthesis, 1 g of total
RNA and 1 M of random nonamers (Gene Link) were used. The
reverse transcription product was 10 times diluted and 10 ng of
cDNA was used for real-time PCR. RNA transcripts were quanti-
fied by using an ABI Prism 7000 sequence detection system
(Applied Biosystems) by using Universal ProbeLibrary Probes
(Roche). Primer and probe sequences are listed in Table S4. For
comparative quantitative analysis, transcript levels were normalized
by using transcript levels of ihf as a standard (9). Data were
processed by using 7000 system SDS software (Applied Biosys-
tems).
Sequencing of lacUV5 Promoters and Genes Encoding T7RNAP. A
stretch of the chromosomal region covering the promoter govern-
ing expression of T7RNAP and the gene encoding T7RNAP was
amplified fromBL21(DE3),C41(DE3), andC43(DE3) by using the
Roche Expand Long Template PCR System and the following
primers: ‘‘T7f’’ and ‘‘T7r.’’ The PCR product was purified on an
agarose gel and extracted by using the QiaexII gel extraction kit
(Qiagen). The PCR product was sequenced by using the BigDye
Terminator v1.1 cycle sequencing kit from Applied biosystems and
the following primers: ‘‘T7seqf,’’ ‘‘T7seqr,’’ ‘‘T7seq243r,’’
‘‘T7seq745r,’’ ‘‘T7seq1180f,’’ ‘‘T7seq1672f,’’ ‘‘T7seq2521f,’’
‘‘T7pseq529r,’’ and ‘‘T7pseq271r’’. For sequence analysis and
alignments Vector NTI software (Invitrogen) was used. Primer
sequences are listed in Table S4.
Construction of pLemo. A portion of pRha109 (10) containing the
genes rhaS, rhaR, the promoter rhaBAD and the multiple cloning
site was PCR amplified by using primers ‘‘pRhaEheIf’’ and
‘‘pRhaXmaJIr’’ (Table S4). The purified PCR product was di-
gested and cloned into the backbone of pACYC-DUET-1 (Nova-
gen) (11) digested with EheI and XmaJI. The XbaI restriction site
within the p15A origin was eliminated by Quikchange site directed
mutagenesis (TCTAGA toTCTAGG) following the instructions of
the manufacturer (Stratagene). The resulting plasmid was named
pTACO2. pLemo was constructed by ligating the PCR-amplified
product of the T7 Lysozyme mutant K128Y (12) into pTACO2
digested with SalI and BamHI. PCR primers used were
‘‘T7LysYSalIf’’ and ‘‘T7LysYBamHIr’’ (Table S4). We used a
variant of T7 lysozyme (K128Y) (LysY) that has no amidase activity
but retains full inhibition of T7 RNA polymerase (12). It should be
noted that there are no differences between the different forms of
T7 lysozyme on overexpression yields (data not shown).
Promoter Swaps. Swaps of the promoters controlling expression of
T7RNAP in BL21(DE3) and C43(DE3) were performed by using
an approach based on the Red Swap method (13). First, a multiple
cloning site was introduced between the FRT site and priming site
P2 of pKD13 by QuikChange site directed mutagenesis (Strat-
agene) by using the following primers: ‘‘pKD13iQCf’’ and
‘‘pKD13iQCr.’’ The resulting plasmid was designated pKD13i.
The promoters controlling expression of T7RNAP in BL21(DE3)
and C43(DE3) were amplified from the PCR products used for the
sequencing by using the primers ‘‘lacUV5NdeIf’’ and
‘‘lacUV5KpnIr.’’ The purified PCR products were digested and
cloned into pKD13i digested with NdeI and KpnI. Primers
‘‘lacUV5ECOLIswapHP1 and ’’lacUV5ECOLIswapHP2i‘‘
were used to amplify the kanamycin resistance cassette from
pKD13i-lacUV5(BL21) and pKD13i-lacUV5mutated(C43), re-
spectively. BL21(DE3) and C43(DE3) harboring plasmid pKD46
(13) were grown in SOB medium supplemented with 100 g/ml
ampicillin and 0.2%L-arabinose and used tomake competent cells.
After electroporation with the PCR product, kanamycin resistant
colonies were isolated on agar plates, which were supplemented
with 30 g/ml kanamycin. A swap of the promoters and insertion
of the kanamycin resistance cassette was verified by PCR with the
following primers: k1, k2 (13), ’’lacUV5U,‘‘ and ’’T7seq243r.‘‘
Each of the two resulting promoter swaps was transduced into
BL21(DE3) and C43(DE3), respectively, by P1 transduction (14).
The resulting strains were designated ’’SW1323 [BL21(DE3) with
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the mutated lacUV5 promoter from C43(DE3)], ‘‘SW1333
[BL21(DE3) with lacUV5 from BL21(DE3)], ’’SW1325
[C43(DE3) with the mutated lacUV5 promoter from C43(DE3)]
and ‘‘SW1335 [C43(DE3) with lacUV5 from BL21(DE3)]. Sub-
sequently, the kanamycin resistance cassette was removed by using
the Flp recombinase (13, 15). To confirm the swaps, promoters
were sequenced as described above by using the primer
’’T7pseq271r.‘‘ For sequence analysis and alignments Vector NTI
software (Invitrogen) was used. Primer sequences are listed in
Table S4.
Analysis of Whole Cell Lysates by 2D-Gel Electrophoresis, Image
Analysis and Statistics. Two-dimensional-gel electrophoresis of
whole cell lysates was performed as described before (16). For
comparative analysis spot intensities were quantified by the
PDQuest v.8.0 software (Bio-Rad). The quantification of saturated
spots and ‘‘trains’’ of spots was approximated by using the ‘‘contour
tool’’ of the program. Spot volumes were normalized by using ‘‘all
valid spots.’’ In total, 483 spots were identified consistently. For
each spot a two-way ANOVA was performed on log transformed
data, with treatment ( protein overexpression) and strain as
factors, resulting in a P value for each spot; 49 spots with missing
data in at least one complete replicate group were excluded from
the ANOVA-analysis, but information about these spots is pro-
vided in Table S2, and marked as ‘‘qualitative’’ information. The P
values were ordered and the calculated false discovery rate
(FDR)0.05-level was 0.014, with FDR0.05 considered significant.
Significant effects [‘‘treatment,’’ ‘‘strain,’’ ‘‘treatment and strain’’
(no interaction), and ‘‘interaction’’] were found for 122 spots (Table
S2 and Table S3).
Analysis of Cytoplasmic Membranes by 2-D Blue Native Electrophore-
sis, Image Analysis and Statistic. Isolation of cytoplasmicmembranes
was carried out as described before by using two subsequent sets of
sucrose density gradients (8). Two-dimensional blue native elec-
trophoresis (2D BN/SDS/PAGE) was performed as described
previously (8, 17). Gels were run with independent triplicate
samples; i.e., each gel contained sample from different bacterial
colonies and cultures. The gels were stained with colloidal Coo-
massie (18) and scanned by using a GS-800 densitometer from
Bio-Rad. For comparative analysis spot intensities were quantified
by the PDQuest v.8.0 software (Bio-Rad). The quantification of
saturated spots was approximated by using the contour tool of the
program. Spot quantities were normalized by using all valid spots.
Output was a list of spots and their intensities in each of the gels
(Table S1). In total, 183 trustworthy spots were identified. For each
spot a two-way ANOVA was performed on log transformed data,
with treatment ( protein overexpression) and strain as factors; 36
spots with missing data in all replicates, for some combination of
treatment and strain, were excluded from the ANOVA-analysis.
The effect of those spots is termed qualitative in Table S1. The
interaction term between treatment and strain was also included in
the model. A test was done of the whole model (H0: intercept only)
resulting in a P value for each spot. The P values were ordered and
the calculated false discovery rate (FDR)0.05-level was 0.0375.A test
with a P value below the FDR0.05-level was considered as signifi-
cant. This approach resulted in 123 spots with some kind of
significant effects in the ANOVA-analysis. A grouping of the spots
on the kind of effect was done. The effects were treatment, strain,
treatment and strain (no interaction) and interaction. The effects
are shown in Table S1. The grouping criteria are shown in Table S3.
Protein Identification by Mass Spectrometry and Bioinformatics. Pro-
teins were identified by peptide mass finger printing by using
MALDI-TOF MS essentially as described in (8) with only a few
modifications. Spectral annotations (in particular assignments of
mono-isotopic masses) were verified by manual inspection for a
large number of measurements. Matrix, autoproteolytic trypsin
fragments, and/or contaminant peaks (e.g., keratin) in MALDI-
TOF spectra were removed by the software Peak Eraser v2.01
(Lighthouse data). A list with removed peaks (assigned masses) is
provided in Table S5. The resulting peptide mass (peak) lists were
used to search the SwissProt 54.6 database (release 12/04/07) for E.
coli (9304 sequences) with Mascot (v2.0; Matrix Science), by using
the following search parameters: significant proteinMOWSE score
at P  0.05, no missed cleavages allowed, variable methionine
oxidation, fixed carbamidomethylation of cysteines, and minimum
mass accuracy 50 ppm. These search results were filtered applying
the following three criteria for positive identification: (i) Minimum
MOWSE score 50, (ii) four matching peptides with an error
distribution within  25 ppm, and (iii) 15% sequence coverage.
The minimum ratio of matched to unmatched peaks accepted was
0.25. Applying these criteria, false positive rates were 1%, as
determined earlier (8). For several critical samples, the peptides
were also analyzed by nano-LC-ESI-MS/MS as described before
(8). Synonymous gene names are given in the tables in supporting
information. Ambiguous protein assignments (resulting from mul-
tiple peptides matching to several proteins) were not occurring.
Activity Measurements of Respiratory Chain Complexes. Succinate
dehydrogenase, FoF1-ATP synthase activities, and NADH con-
sumption of inverted membrane vesicles isolated from cells
overexpressing YidC-GFP and control cells harvested 4 h after
induction were determined as described previously (19, 20).
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Blue Native - PAGE
Fig. S1. Analysis of cytoplasmic membrane fractions by 2D BN/SDS/PAGE. Cells expressing YidC-GFP and control cells were cultured as described in the SI
Materials and Methods and harvested four hrs after addition of IPTG. Isolated cytoplasmic membranes were analyzed by 2D blue native electrophoresis (2D
BN/SDS/PAGE) as described in the SIMaterials andMethods. One representative gel of each group is shown. The indicated proteins were identified by MALDI-TOF
MS and PMF, and nano-LC-ESI-MS/MS as described in SI Materials and Methods. Spot numbers are shown on the gel of the replicate group were they had the
highest accumulation levels. The spot numbers refer to Table S1.
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Fig. S2. Effect of YidC-GFP overexpression on the inner membrane proteome and on the performance of respiratory chain complexes of BL21(DE3)pLysS,
C41(DE3), and C43(DE3). Cytoplasmic membranes of cells overexpressing GFP-fusion proteins and of control cells were isolated as described in SI Materials and
Methods. Cytoplasmic membrane isolates were analyzed by 2D BN/SDS/PAGE as described in SI Materials and Methods. Correlation coefficients of protein
accumulation levels were calculated by PDQuest v.8.0. Correlation coefficients within a replicate group (gray fill) are calculated from the spot intensities of the
replicate gels of a certain group. Correlation coefficients between replicate groups (no fill) are based on the mean values of each replicate group (A). Cells
expressing YidC-GFP and control cells were cultured as described in SI Materials and Methods and harvested 4 h after addition of IPTG. Isolation of cytoplasmic
membranes was carried out as described in SIMaterials andMethods. Succinate dehydrogenase, FoF1-ATP synthase activities, and NADH consumption of inverted
membrane vesicles isolated from cells overexpressing YidC-GFP and control cells harvested 4 h after induction were determined as described in SI Materials and
Methods. Activities of BL21(DE3)pLysS control cells were set to 100 (B).



















































































































































































































Fig. S3. Analysis of whole cell lysates by 2D-gel electrophoresis. Cells expressing YidC-GFP and control cells were cultured as described in SI Materials and
Methods section and harvested 4 h after addition of IPTG. Two-dimensional-gel electrophoresis of whole cell lysates was performed as described in SI Materials
andMethods. Quantification data and results of the ANOVA analysis are shown in Table S2. One representative gel of each group is shown. The indicated proteins
were identified by MALDI-TOF MS and PMF as described in SI Materials and Methods. Spot numbers are shown on the gel of the replicate group where they
had the highest accumulation level. The spot numbers refer to Table S2.





























































Fig. S4. Relative quantification of spots representing cytoplasmic proteins analyzed by 2D-gel electrophoresis. (A) proteins that are part of energy generating
systems that showed significantly changed accumulation levels (P value below false discovery rate (FDR) 0.05-level in two-way ANOVA) in Coomassie stained
2D-gels of whole cell lysates of cells overexpressing YidC-GFP for 4 h and the control. For each protein, the value of the strain showing the highest accumulation
levels was set to 100. Primary gene names were taken from Swiss-Prot (www.expasy.org). Numbers behind gene names refer to spots in Table S2 and Fig. S3. An
asterisk behind the gene name indicates that two proteins were identified in a particular spot, the annotation is therefore tentative. In the Walker strains the
accumulation levels of components involved in the TCA cycle and glyoxylate-bypass were less decreased, and components involved in glycolysis and the
acetate-pta pathway less increased, than in BL21(DE3)pLysS. This points to less activation of the Arc two-component system, which mediates adaptive responses
to changing respiratory conditions by monitoring the redox state of the Q pool, in the Walker strains (21). This is in keeping with the oxygen consumption
measurements over time (Fig. 1G). (B) secretory proteins that showed significantly changed accumulation levels (seeA for details). Gene names in italics indicate
precursor forms of secretory proteins.
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Fig. S5. Map of pLemo.
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Fig. S6. Correlation between the formation of cytoplasmic protein aggregates in Lemo21(DE3) and T7 lysozyme expression. Protein aggregates were isolated
from Lemo21(DE3) overexpressing YidC-GFP in the presence of different concentrations of L-rhamnose. The aggregates were analyzed by 1D SDS/PAGE and gels
were stained with colloidal Coomassie. Lemo21(DE3) with an empty overexpression plasmid cultured in the presence of 500 M L-rhamnose was the control (A).
Quantification of the fraction of aggregated proteins in Lemo21(DE3) cells overexpressing YidC-GFP in the presence of different concentrations of L-rhamnose.
Lemo21(DE3) with an empty overexpression plasmid cultured in the presence of 500 mM L-rhamnose was the control (B). Accumulation levels of ClpB and IbpA/B
over time on induction of YidC-GFP expression in Lemo21(DE3) in the presence of 0 and 1,000M L-rhamnose (C). Accumulation levels of IbpA/B in Lemo21(DE3)
cells expressing YidC-GFP at different concentrations of L-rhamnose harvested 4 h after induction with IPTG. Lemo21(DE3) with an empty overexpression plasmid
cultured in the presence of 500 mM L-rhamnose was the control (D).
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Table S3. Grouping criteria ANOVA analysis
Treatment Strain Treatment and strain (no interaction) Interaction
P value treatment 0.05 0.05 0.05 0–1
P value strain 0.05 0.05 0.05 0–1
P value interaction 0.05 0.05 0.05 0.05
Wagner et al. www.pnas.org/cgi/content/short/0804090105 9 of 11
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Other Supporting Information Files
Table S1 (XLS)
Table S2 (XLS)
Table S5. Removed peaks of spectra obtained by MALDI-TOF using Peak Erazor
Blank Keratin Keratin 1 Keratin 8 Keratin 9 Keratin 10 Keratin 18 Trypsin Unknown
553.2600 1060.5170 758.4520 1105.5676 1277.5796 807.4001 848.4114 842.5100 832.3500
662.3500 1126.5400 874.4990 2297.2213 1307.6714 1031.5988 1037.5705 856.5100 870.5000
700.4400 2193.9820 973.5310 2510.3188 2299.2169 1064.6104 864.5100 1036.3800
737.4200 1033.5160 2705.1538 1090.5315 906.5049 1091.5300
750.2800 1066.5169 3264.5066 1109.4904 1045.5642 1108.4200
772.4100 1127.5407 1365.6399 2211.1046 1108.4200
778.3100 1175.6310 1381.6487 2225.3000 1234.6100
804.3500 1179.6010 1707.7727 2239.1000 1277.7200




















Wagner et al. www.pnas.org/cgi/content/short/0804090105 11 of 11
